Genetic heterogeneity "Genetic heterogeneity (two or more fundamentally distinct entities that share approximately the same phenotype) is the rule. If a disorder is thought to be a single entity, it usually means that the disorder is not well understood." McKusick (1972) The importance of an accurate diagnosis in assessing genetic risk cannot be overemphasized, particularly when the family history does not give a clear indication of the mode of transmission. It has become apparent that in many instances more than one genetic cause leads to the same or a similar clinical appearance (heterogeneity), and what was once thought to be a single entity has proved on close study to consist of several distinct disorders. Three examples of genetic heterogeneity will be used to illustrate this point.
Albinism
One of the original "Inborn Errors of Metabolism" described by Sir Archibald Garrod (I909) was albinism, a condition of considerable antiquity widely distributed both in the various races of man and in the rest of the animal kingdom. Albinism has for long been of interest to ophthalmologists and one of the earliest classifications of this heterogeneous group of disorders was that of Pearson, Nettleship, . Their classification, although inaccurate and incomplete in the light of our present knowledge, was not superseded until Fitzpatrick and Quevedo (I966) , divided albinism into oculocutaneous, ocular, and cutaneous forms. More recently, Witkop (I 97I) has further subdivided oculocutaneous albinism on the basis of the tyrosinase test (Kugelman and Van Scott, I961) into tyrosinase-positive and tyrosinase-negative forms. His study of two families (Witkop, Nance, Rawls, and White, I970), one being being the family originally reported by Trevor-Roper (1952) , demonstrated that parents with the two different forms of oculocutaneous albinism produce normal offspring, thus indicating that the genes responsible for these two forms are situated at different genetic loci. Witkop's classification of albinism (Witkop, I97I) includes a number of hypopigmentary disorders which Fitzpatrick and Quevedo (1972) believe should not now be included under the general heading of albinism; it is clinically useful, however, to consider these conditions together (Table I) . It is Witkop's impression (Jay, 1972) . These observations are relevant, not only to genetic counselling, but also to studies aimed at determining the aetiology of retinitis pigmentosa. It is probable that each genetic form of the disease has a different underlying abnormality, and only by studying these different forms separately will meaningful conclusions be reached.
Mucopolysaccharidoses
While the underlying defects in the various genetic forms of isolated retinitis pigmentosa
have not yet been established, considerable progress has recently been made in our understanding of another group of disorders which also demonstrates genetic heterogeneity, the mucopolysaccharidoses (Table III) . These uncommon and rare disorders are of interest to ophthalmologists as several of the conditions in this group are associated with corneal clouding. All but MPS II, the Hunter syndrome which is X-linked, are transmitted as autosomal recessive traits. (Jensen, 197 Topping, Green, and Maumenee, 1972) . There is excessive urinary excretion of dermatan sulphate and the fundamental defect is the absence of a specific corrective factor. There is some evidence that MPS VI itself exhibits genetic heterogeneity, there being a clinically milder form also showing absence of the same specific corrective factor.
MPS VII
The most recent entity to be recognized as a specific mucopolysaccharidosis is MPS VII, P-glucuronidase deficiency (Beaudet, Di Ferrante, Nichols, and Ferry, 1972; Sly, Quinton, McAlister, and Rimoin, I973). Clinical features include dwarfism, hepatosplenomegaly, and inclusions in leucocytes. So far, corneal changes have not been seen. McKusick (I972) gives a detailed account of this and other mucopolysaccharidoses.
Detection of heterozygous states As our investigation of the heterozygous state becomes more sophisticated, so does its detection become more frequent. In X-linked traits where the abnormality is manifested in (hemizygous) males, and occasionally in homozygous females, it is becoming increasingly common for minor abnormalities to be described in heterozygous ("carrier") females. The identification of these heterozygous females is particularly important in genetic counselling, as 50 per cent. of their male offspring will be affected. The advent of amniocentesis, which allows the determination of fetal sex early in pregnancy, offers the opportunity for a therapeutic abortion of a male fetus if the condition is severe.
In "Mendelian Inheritance (Table IV) . These abnormalities vary considerably in severity Bosch (1959) from one disorder to another, and even in one disorder from one heterozygote to another. In some disorders the heterozygous state can easily be ascertained clinically, in some the abnormalities are inconstantly present, while in others the heterozygous phenotype varies from almost normal to a severity almost equal to that of affected males. Examples of this variability of the heterozygous state will be given.
Choroideremia
The appearance of the fundus in females heterozygous for choroideremia was first described as such by Waardenburg (1942) and Goedbloed (1942) , although there are earlier reports in the literature of mild fundus changes in female relatives of patients with choroideremia without the significance of these changes having been appreciated. In most of these earlier reports the changes were described as pigment anomalies, most marked in the group.bmj.com on June 21, 2017 -Published by http://bjo.bmj.com/ Downloaded from periphery of the retina, and were considered to be congenital and stationary and not usually associated with any functional deficit. Kurstjens (I965) described his findings in 45 affected males and 6I heterozygous females. In the females the striking feature was the wide variation in the appearance of the fundus, ranging from very slight pigmentary changes in the retina to features closely resembling those seen in affected males; there was also considerable intrafamilial variation in these changes. In four of these heterozygous females progression of the changes in the fundus were noted, associated with a reduction in the visual acuity. Three of these four heterozygotes complained of night-blindness, had abnormal dark adaptation curves, extensive defects in their visual fields, severe electroretinographic changes, and an absence of light rise in the electro-oculogram. These progressive changes in the fundus, associated with functional deficits, were observed to occur later in life than in affected males. In this large group of heterozygous females, the most common appearance of the fundus was, however, the presence of fine equatorial and peripheral pigmentation, often in a striated and radiating pattern, and unassociated with functional deficits.
Retinitis pigmentosa
The appearance of the fundus in females heterozygous for X-linked retinitis pigmentosa has been of particular interest since the description of the tapetal reflex by Falls and Cotterman (1948) . A number of isolated reports have appeared over the past 25 years, but it is the two large studies by Schappert-Kimmijser (i963) and byJay and Bird (I973) that have indicated the wide interfamilial and intrafamilial variation in the appearances of the fundus in these heterozygous females. In the series of nineteen families reported by Jay and Bird (1973) , 42 heterozygous females were examined, 39 of whom had a visual acuity better than 6/i8. Several females who were presumed to have been heterozygous but who were not examined were said to have become blind in old age. Almost all heterozygous females had changes in the fundus. A few had a glistening tapetal reflex, but this was neither a common nor a particularly helpful change. A number had a characteristic granular retinal periphery with small white dots scattered over it. The most characteristic changes were segmental areas of atrophy of the pigment epithelium with pigmentary migration into the retina. A few fundi showed segmental retinitis pigmentosa or even frank generalized retinitis pigmentosa. Small defects in the visual fields were usually demonstrable corresponding to the areas of greatest retinal involvement. In those heterozygous females with gross retinal changes, the field changes were correspondingly gross, but never as extensive as the changes found in affected males of similar age. The final rod threshold of dark adaptation was almost always raised by 0-5 to 1-5 log units in patients with minor involvement, the EOG light-induced rise in potential was usually between ioo and i6o per cent., and ERG changes occurred in the more severely affected females.
Identification of carriers
The importance of identifying heterozygous females in X-linked conditions is obvious, as 50 per cent. of their male offspring will be affected. The identification of heterozygotes (carriers) in autosomal recessive conditions is far less often of practical importance. Autosomal recessive conditions tend to be uncommon or rare and the chances of a carrier marrying another carrier with the same abnormal gene are very small, as long as they are not related. In certain instances, however, this identification of the carrier state is relevant, particularly in the screening of whole populations especially at risk. Such identification is already being carried out in parts of Italy, where io per cent. or more of the population carry the gene for thalassaemia; it has been suggested for the sickle-cell trait in Negroes, so that couples found to be at risk can be offered antenatal diagnosis to prevent the birth of affected children (Hollenberg, Kaback, and Kazazian, 1971) (Delvin, Scriver, Pottier, Clow, and Goldmann, 1972) . In this last disease, Aronson (Evans, 1973) . The identification of the carrier state in autosomal recessive disorders is stillin its infancy. It is inevitable that, with the demonstration of the basic enzymatic defect in each of these conditions, and with the increasingly sophisticated biochemical estimations of these enzymes, the list of disorders in which the carrier state will be identifiable will grow very fast over the next few years.
Antenatal diagnosis
About 20 years ago it was shown that the sex of a fetus could be determined by examining the sex chromatin of cells in amniotic fluid. About IO years ago these cells were cultured and their chromosomes studied, thus determining the chromosome constitution of the fetus. Nadler (I968) demonstrated that these fetal cell cultures could be used for the antenatal diagnosis of certain biochemical disorders. In ophthalmic genetic counselling we are particularly concerned with the determination of fetal sex and with the identification of certain genetically-determined disorders by studying amniotic fluid, a study which can now be undertaken at about I4 weeks of pregnancy. No mention will be made here of chromosome studies, a subject which does not fall within the scope of this article.
The determination of fetal sex is relevant in conditions transmitted by genes on the X-chromosome. An affected male with an X-linked disorder will produce normal sons and heterozygous (carrier) daughters, while a female who is heterozygous for an X-linked disorder will produce 50 per cent. affected sons and 50 per cent. carrier daughters. In X-linked disorders with severe effects, it is reasonable to consider the termination of a pregnancy if there is a 'substantial risk' of a serious abnormality in the fetus. The determination of fetal sex by amniocentesis can therefore be offered to heterozygous females as long as termination of the pregnancy would be acceptable if the fetus were male. Amniocentesis can be offered, for example, to those heterozygous females for X-linked retinitis pigmentosa or for choroideremia who do not wish to produce an affected son. The longterm dysgenic effects of this policy have to be considered. The abortion of all males from carrier mothers with full reproductive compensation (the ultimate size of the family being unaffected by any terminations of pregnancy that are performed) will result in the gene frequency rising linearly with time (Motulsky, Fraser, and Felsenstein, I97I Bittles and Carson (1973) Suzuki, Schneider, and Epstein (1971) Nadler and Gerbie (1970) Epstein, Brady, Schneider, Bradley, and Shapiro (1971) Uhlendorf, Jacobson, Sloan, Mudd, Herndon, Brady, Seegmiller, and Fujimoto (1969) the basic enzymatic defect is known and when the enzyme has wide tissue distribution. If the enzyme is expressed in cultured skin fibroblasts, it will probably be demonstrable in amniotic fluid cells. It is only recently that the basic enzymatic defects have been demonstrated for some of the mucopolysaccharidoses (Table III) and as yet there are no reports in the literature of antenatal diagnosis being based on their absence from amniotic fluid cells. Up to the present time, the antenatal diagnosis of the mucopolysaccharidoses has depended upon the increased incorporation of radioactive sulphate in cultured amniotic fluid cells (Fratantoni, Neufeld, Uhlendorf, and Jacobson, i969) , or upon the analysis of mucopolysaccharides in amniotic fluid (Matalon, Dorfman, Nadler, and Jacobson, I970) . The problems inherent in these methods are discussed by Crawfurd, Dean, Hunt, Johnson, MacDonald, Muir, Wright, and Wright (1973) . It is expected that a direct assay of the specific enzyme in amniotic cells will soon be possible in this group of disorders, as it will in many other inborn errors of metabolism. For a detailed account of the current position in the antenatal diagnosis of ge ietic disease, reference should be made to Emery (I 973). Summary Some of the recent advances which have influenced our assessment of genetic risk in hereditary disorders of the eye are discussed. The importance of making an exact diagnosis is emphasized, and the concept of genetic heterogeneity is illustrated by three groups of disorders: albinism, retinitis pigmentosa, and the mucopolysaccharidoses. The value of recognizing the heterozygous state in X-linked and in autosomal recessive traits is discussed and the clinical variability of heterozygotes for choroideremia and for X-linked retinitis pigmentosa is described. Two aspects of antenatal diagnosis are considered. The implications of the determination of foetal sex for females heterozygous for X-linked traits is discussed. The current position regarding the detection of biochemical abnormalities in the foetus is stated. 
